The Management of Non-Hodgkin’s Lymphomas in Europe:
The European School of Oncology came into existence to respond to a need for informa tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorousl...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1990
|
Schriftenreihe: | ESO Intercity Report
|
Schlagworte: | |
Online-Zugang: | UBR01 URL des Erstveröffentlichers |
Zusammenfassung: | The European School of Oncology came into existence to respond to a need for informa tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and its seminars on new techniques or on the principal therapeutic controversies, it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the Uni versity and Industry and between these two and daily medical practice. One of the more recent initiatives of the ESO is the Intercity Meetings. The concept of Inter city Meetings was first put forward with the idea of creating total coverage throughout Europe of certain tumours at the forefront of research and, in some cases, controversy |
Beschreibung: | 1 Online-Ressource (VIII, 92 p. 6 illus) |
ISBN: | 9783642755286 |
DOI: | 10.1007/978-3-642-75528-6 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046145446 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s1990 |||| o||u| ||||||eng d | ||
020 | |a 9783642755286 |9 978-3-642-75528-6 | ||
024 | 7 | |a 10.1007/978-3-642-75528-6 |2 doi | |
035 | |a (ZDB-2-SME)978-3-642-75528-6 | ||
035 | |a (OCoLC)1118992187 | ||
035 | |a (DE-599)BVBBV046145446 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.994 |2 23 | |
245 | 1 | 0 | |a The Management of Non-Hodgkin’s Lymphomas in Europe |c edited by Silvio Monfardini |
264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1990 | |
300 | |a 1 Online-Ressource (VIII, 92 p. 6 illus) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a ESO Intercity Report | |
520 | |a The European School of Oncology came into existence to respond to a need for informa tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and its seminars on new techniques or on the principal therapeutic controversies, it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the Uni versity and Industry and between these two and daily medical practice. One of the more recent initiatives of the ESO is the Intercity Meetings. The concept of Inter city Meetings was first put forward with the idea of creating total coverage throughout Europe of certain tumours at the forefront of research and, in some cases, controversy | ||
650 | 4 | |a Oncology | |
650 | 4 | |a Endocrinology | |
650 | 4 | |a Oncology | |
650 | 4 | |a Endocrinology | |
650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Non-Hodgkin-Lymphom |0 (DE-588)4115403-4 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Non-Hodgkin-Lymphom |0 (DE-588)4115403-4 |D s |
689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Monfardini, Silvio |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540522973 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642755293 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-75528-6 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031525631 | ||
966 | e | |u https://doi.org/10.1007/978-3-642-75528-6 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180482092433408 |
---|---|
any_adam_object | |
author2 | Monfardini, Silvio |
author2_role | edt |
author2_variant | s m sm |
author_facet | Monfardini, Silvio |
building | Verbundindex |
bvnumber | BV046145446 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-3-642-75528-6 (OCoLC)1118992187 (DE-599)BVBBV046145446 |
dewey-full | 616.994 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.994 |
dewey-search | 616.994 |
dewey-sort | 3616.994 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-3-642-75528-6 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03069nmm a2200505zc 4500</leader><controlfield tag="001">BV046145446</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1990 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642755286</subfield><subfield code="9">978-3-642-75528-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-75528-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-75528-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118992187</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046145446</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The Management of Non-Hodgkin’s Lymphomas in Europe</subfield><subfield code="c">edited by Silvio Monfardini</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (VIII, 92 p. 6 illus)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">ESO Intercity Report</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The European School of Oncology came into existence to respond to a need for informa tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and its seminars on new techniques or on the principal therapeutic controversies, it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the Uni versity and Industry and between these two and daily medical practice. One of the more recent initiatives of the ESO is the Intercity Meetings. The concept of Inter city Meetings was first put forward with the idea of creating total coverage throughout Europe of certain tumours at the forefront of research and, in some cases, controversy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Non-Hodgkin-Lymphom</subfield><subfield code="0">(DE-588)4115403-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Non-Hodgkin-Lymphom</subfield><subfield code="0">(DE-588)4115403-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Monfardini, Silvio</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540522973</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642755293</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-75528-6</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031525631</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-75528-6</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
id | DE-604.BV046145446 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:27Z |
institution | BVB |
isbn | 9783642755286 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031525631 |
oclc_num | 1118992187 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (VIII, 92 p. 6 illus) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 1990 |
publishDateSearch | 1990 |
publishDateSort | 1990 |
publisher | Springer Berlin Heidelberg |
record_format | marc |
series2 | ESO Intercity Report |
spelling | The Management of Non-Hodgkin’s Lymphomas in Europe edited by Silvio Monfardini Berlin, Heidelberg Springer Berlin Heidelberg 1990 1 Online-Ressource (VIII, 92 p. 6 illus) txt rdacontent c rdamedia cr rdacarrier ESO Intercity Report The European School of Oncology came into existence to respond to a need for informa tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and its seminars on new techniques or on the principal therapeutic controversies, it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the Uni versity and Industry and between these two and daily medical practice. One of the more recent initiatives of the ESO is the Intercity Meetings. The concept of Inter city Meetings was first put forward with the idea of creating total coverage throughout Europe of certain tumours at the forefront of research and, in some cases, controversy Oncology Endocrinology Oncology Therapie (DE-588)4059798-2 gnd rswk-swf Non-Hodgkin-Lymphom (DE-588)4115403-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Non-Hodgkin-Lymphom (DE-588)4115403-4 s Therapie (DE-588)4059798-2 s DE-604 Monfardini, Silvio edt Erscheint auch als Druck-Ausgabe 9783540522973 Erscheint auch als Druck-Ausgabe 9783642755293 https://doi.org/10.1007/978-3-642-75528-6 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | The Management of Non-Hodgkin’s Lymphomas in Europe Oncology Endocrinology Oncology Therapie (DE-588)4059798-2 gnd Non-Hodgkin-Lymphom (DE-588)4115403-4 gnd |
subject_GND | (DE-588)4059798-2 (DE-588)4115403-4 (DE-588)1071861417 |
title | The Management of Non-Hodgkin’s Lymphomas in Europe |
title_auth | The Management of Non-Hodgkin’s Lymphomas in Europe |
title_exact_search | The Management of Non-Hodgkin’s Lymphomas in Europe |
title_full | The Management of Non-Hodgkin’s Lymphomas in Europe edited by Silvio Monfardini |
title_fullStr | The Management of Non-Hodgkin’s Lymphomas in Europe edited by Silvio Monfardini |
title_full_unstemmed | The Management of Non-Hodgkin’s Lymphomas in Europe edited by Silvio Monfardini |
title_short | The Management of Non-Hodgkin’s Lymphomas in Europe |
title_sort | the management of non hodgkin s lymphomas in europe |
topic | Oncology Endocrinology Oncology Therapie (DE-588)4059798-2 gnd Non-Hodgkin-Lymphom (DE-588)4115403-4 gnd |
topic_facet | Oncology Endocrinology Oncology Therapie Non-Hodgkin-Lymphom Konferenzschrift |
url | https://doi.org/10.1007/978-3-642-75528-6 |
work_keys_str_mv | AT monfardinisilvio themanagementofnonhodgkinslymphomasineurope |